Alector - Funding, Financials, Valuation & Investors - Crunchbase

Feb 7, 2019 · Their latest funding was raised on Jan 17, 2024 from a Post-IPO Equity round. Alector is registered under the ticker NASDAQ:ALEC . Their stock opened with $19.00 in its …

CouponFollow Extension

$19.00
OFF

Alector - Funding, Financials, Valuation & Investors - Crunchbase

1 week from now

Feb 7, 2019 · Their latest funding was raised on Jan 17, 2024 from a Post-IPO Equity round. Alector is registered under the ticker NASDAQ:ALEC . Their stock opened with $19.00 in its …

crunchbase.com

$5.75
OFF

Alector Company Profile 2024: Stock Performance & Earnings

1 week from now

Alector Valuation & Funding. Deal Type Date Amount Valuation/ EBITDA Post-Val Status ... As of 08-Nov-2024 the stock price of Alector is $5.75. What is the current market cap of Alector? …

pitchbook.com

$194
OFF

Alector Stock Price, Funding, Valuation, Revenue & Financial …

1 week from now

Feb 7, 2019 · Funding, Valuation & Revenue. 7 Fundings. Alector has raised $194.5M over 7 rounds. Alector's latest funding round was a IPO for $166.5M on February 7, 2019. Alector's …

cbinsights.com

$15
OFF

Alector Reports First Quarter 2024 Financial Results And Provides ...

1 week from now

May 8, 2024 · First Quarter 2024 Financial Results. Revenue. Collaboration revenue for the quarter ended March 31, 2024, was $15.9 million, compared to $16.5 million for the same …

alector.com

36%
OFF

Alector, Inc. (ALEC) Stock Price, Quote & News - Stock Analysis

1 week from now

Get a real-time Alector, Inc. (ALEC) stock price quote with breaking news, financials, statistics, charts and more. ... Alector's revenue was $97.06 million, a decrease of -27.36% compared to …

stockanalysis.com

58%
OFF

Alector, Inc. (ALEC) Statistics & Valuation Metrics - Stock Analysis

1 week from now

The stock price has decreased by -0.58% in the last 52 weeks. The beta is 0.68, so Alector's price volatility has been lower than the market average. Beta (5Y)

stockanalysis.com

$0.43
OFF

Alector Secures Funding To Advance Clinical Trials

1 week from now

4 days ago · Alector GAAP EPS of -$0.43 beats by $0.14, revenue of $15.34M misses by $0.55M Seeking Alpha 9d Alector’s Promising Phase 2 Study and Strong Financial Outlook Justify Buy …

businessinsider.com

$97.06
OFF

Alector Company Profile - Office Locations, Competitors, Revenue ...

1 week from now

Oct 29, 2024 · Alector has 5 employees at their 1 location and $97.06 m in annual revenue in FY 2023. See insights on Alector including office locations, competitors, revenue, financials, …

craft.co

$15
OFF

Alector Reports Third Quarter 2024 Financial Results And Provides ...

1 week from now

Nov 6, 2024 · Alector Reports Third Quarter 2024 Financial Results and Provides Business Update ... Collaboration revenue for the quarter ended September 30, 2024, was $15.3 million, …

morningstar.com

$5.13
OFF

Alector Stock Price Today (NASDAQ: ALEC) Quote, Market Cap, …

1 week from now

5 days ago · With Alector stock trading at $5.13 per share, the total value of Alector stock (market capitalization) is $501.90M. Alector stock was originally listed at a price of $18.00 in Feb 7, …

wallstreetzen.com

$9
OFF

Alector’s Strong Outlook: Advancing Pipeline And Undervalued …

1 week from now

Aug 13, 2024 · His projection for the stock’s performance is also grounded in a detailed discounted cash flow analysis, which extends to the year 2037, maintaining a price target of $9.

businessinsider.com

$50
OFF

Alector Secures Flexible Credit Facility For Up To $50 Million From ...

1 week from now

4 days ago · SOUTH SAN FRANCISCO, Calif., Nov. 14, 2024 (GLOBE NEWSWIRE) -- Alector, Inc. (Nasdaq: ALEC), a clinical-stage biotechnology company pioneering immuno-neurology, …

alector.com

FAQs about Alector - Funding, Financials, Valuation & Investors - Crunchbase Coupon?

How much money did Alector make in first quarter 2024?

SOUTH SAN FRANCISCO, Calif., May 08, 2024 (GLOBE NEWSWIRE) -- Alector, Inc. (Nasdaq: ALEC), a clinical-stage biotechnology company pioneering immuno-neurology, today reported first quarter 2024 financial results and recent portfolio and business updates. As of March 31, 2024, Alector’s cash, cash equivalents and investments totaled $562.1 million. ...

Should you buy Alector (Alec – research report)?

In a report released today, Graig Suvannavejh from Mizuho Securities reiterated a Buy rating on Alector ( ALEC – Research Report ), with a price target of $9.00. Graig Suvannavejh has given his Buy rating due to a combination of factors, including Alector’s steady progress in advancing its pipeline, particularly in neurodegenerative diseases. ...

Who is Alector (Alec)?

Alector ( (ALEC) ) has provided an update. Alector, a clinical-stage biotechnology company, has secured a $50 million credit facility from Hercules Capital. ...

Where is Alector located?

Alector is located in San Francisco, California, United States. Who invested in Alector? Alector has 20 investors including OrbiMed and Mission Bay Capital. How much funding has Alector raised to date? Alector has raised When was the last funding round for Alector? Alector closed its last funding round on Jan 17, 2024 from a Post-IPO Equity round. ...

What was Alector's net loss?

Net Loss. For the quarter ended March 31, 2024, Alector reported a net loss of $36.1 million, or $0.38 per share, compared to a net loss of $45.9 million, or $0.55 net loss per share, for the same period in 2023. ...

Why did Alector's stock go down 18% compared to last year?

Alector's stock has traded mostly sideways, down 18% from last year, despite having a promising late-stage CNS pipeline, loads of cash, and two big partnerships. The company has trimmed down its pipel... ...